 Home > Medical News > Latest Medical News > Huadong Medicine MB-102 injection clinical trial application was accepted

Huadong Medicine MB-102 injection clinical trial application was accepted

 Last Update: 2021-03-22
 Source: Internet
 Author: User

Tags

real time cream

lyrica drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 9th, Huadong Medicine issued an announcement stating that its wholly-owned subsidiary Sino-American Huadong received the "Notice of Acceptance" approved and issued by NMPA, and the application for the clinical trial of the first class new drug MB-102 injection declared by Sino-American Huadong and MediBeacon Get accepted.

MB-102 is a fluorescent tracer used to measure the glomerular filtration rate.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.